ClinicalTrials.Veeva

Menu

Bioavailability of Plant Protein Amino Acids

U

University of Limerick

Status

Completed

Conditions

Bioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy Men

Treatments

Dietary Supplement: Chickpea protein concentrate
Dietary Supplement: Fava-bean protein concentrate
Dietary Supplement: Non-essential amino acid blend
Dietary Supplement: Pea-protein concentrate
Dietary Supplement: Whey protein concentrate
Dietary Supplement: Red lentil protein concentrate

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04872530
2019_12_02_EHS

Details and patient eligibility

About

This study aims to inform of the mechanism of action of plant-based protein by measuring the bioavailability (i.e. rate of appearance and magnitude of concentration in the circulation following oral ingestion) of key amino acid and metabolic products that regulate skeletal muscle protein synthesis (MPS) in humans.

Full description

Plant-based proteins contain several amino acids that are essential to signal muscle growth/repair and act as a substrate during muscle protein synthesis. However, compared to animal protein or free-amino acids, the bioavailability of certain essential amino acids may be compromised. Following selective processing (e.g. removal of carbohydrate and/or other anti-nutritive factors) food grade plant-based protein concentrates possibly confer greater bioavailability and bioactivity in vivo. This project explores the bioavailability and bioactivity of selected plant-based protein concentrates following oral ingestion in young, healthy men and women.

Enrollment

10 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • No known intolerance to any item contained in the protein products.
  • No blood borne disease risk, current illness or medication that would adversely affect participation
  • No known adverse reaction to venepuncture

Exclusion criteria

  • n/a

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

10 participants in 6 patient groups

Pea-protein concentrate
Experimental group
Description:
Pea-protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Treatment:
Dietary Supplement: Pea-protein concentrate
Fava-bean protein concentrate
Experimental group
Description:
Fava-bean protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Treatment:
Dietary Supplement: Fava-bean protein concentrate
Chickpea protein concentrate
Experimental group
Description:
Chickpea protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Treatment:
Dietary Supplement: Chickpea protein concentrate
Red lentil protein concentrate
Experimental group
Description:
Red lentil protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Treatment:
Dietary Supplement: Red lentil protein concentrate
Non-essential amino acid blend
Experimental group
Description:
Non-essential amino acid blend dosed at 0.33 g/kg body mass in 500 ml of water.
Treatment:
Dietary Supplement: Non-essential amino acid blend
Whey protein concentrate
Experimental group
Description:
Whey protein concentrate dosed at 0.33 g/kg body mass in 500 ml of water.
Treatment:
Dietary Supplement: Whey protein concentrate

Trial contacts and locations

1

Loading...

Central trial contact

Rob Davies, PhD; Phil Jakeman, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems